首页> 外文期刊>The international journal of artificial organs >Impact of blood and dialysate flow and surface on performance of new polysulfone hemodialysis dialyzers.
【24h】

Impact of blood and dialysate flow and surface on performance of new polysulfone hemodialysis dialyzers.

机译:血液,透析液流量和表面对新型聚砜血液透析透析器性能的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Optimization of hemodialysis treatment parameters and the characteristics of the dialyzer are crucial for short- and long-term outcome of end stage renal disease patients. The new high-flux membrane Helixone in the dialyzer of the FX series (Fresenius Medical Care, Germany) has interesting features, such as the relationship of membrane thickness and capillary diameter which increases middle molecule elimination by convection, as well as higher capillary packing and microondulation to improve the dialysate flow and distribution. Blood flow, dialysate flow and surface area are the main determinants of the performance of a dialyzer, however the impact of each parameter on small and middle molecule clearance in high flux dialysis has not been well explored. In order to find the best treatment condition for the new dialyzer series, we evaluated urea, creatinine, phosphate clearances and reduction rate of beta2-microglobulin in ten stable patients treated with different blood flows (effective Qb 280 and 360 ml/min), dialysate flow (Qd 300 or 500 ml/min) and dialyzer surfaces (1.4 and 2.2 m2, FX60 or FX100). KoA and Kt/V were also calculated. Blood flow, dialysate flow and surface area demonstrated a significant and independent effect on clearance of urea, creatinine and phosphate, as well as on Kt/V. Small solute clearance was stable over the treatment. In contrast to small solutes, reduction rate of beta2-microglobulin was related to increasing dialyzer surface only. The new dialyzer design of the FX series proves highly effective due to improved dialysate distribution and reduced diffusive resistance as shown by the small solute clearance. A high reduction rate of beta2-microglobulin is favored by improved fiber geometry and pore size distribution. These findings have potential long-term benefits for the patient.
机译:血液透析治疗参数的优化和透析器的特性对于终末期肾病患者的短期和长期结果至关重要。 FX系列透析器中的新型高通量膜Helixone(Fresenius Medical Care,德国)具有有趣的功能,例如膜厚度与毛细管直径之间的关系可增加对流消除中间分子,以及更高的毛细管堆积和微调制可改善透析液的流量和分布。血流量,透析液流量和表面积是透析器性能的主要决定因素,但是,在高通量透析中,每个参数对中小分子清除率的影响尚未得到很好的研究。为了找到新的透析器系列的最佳治疗条件,我们评估了十名采用不同血流量(有效Qb 280和360 ml / min),透析液治疗的稳定患者的尿素,肌酐,磷酸盐清除率和β2-微球蛋白的降低率。流量(Qd 300或500 ml / min)和透析器表面(1.4和2.2 m2,FX60或FX100)。还计算了KoA和Kt / V。血流量,透析液流量和表面积显示出对尿素,肌酐和磷酸盐的清除以及对Kt / V的显着且独立的影响。在整个处理过程中,小的溶质清除率是稳定的。与小的溶质相反,β2-微球蛋白的减少率仅与增加透析器表面有关。 FX系列的新型透析器设计由于改善了透析液的分布并降低了扩散阻力(如溶质清除率较小)而被证明具有很高的效率。改进的纤维几何形状和孔径分布有利于β2-微球蛋白的高还原率。这些发现对患者有潜在的长期益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号